Pierre Fabre Overview

  • Year Founded
  • 1961

Year Founded

  • Status
  • Private

  • Employees
  • 9,600

Employees

Pierre Fabre General Information

Description

Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medical innovation. The company's services are offered through an innovation laboratory that promotes research and development in pharmaceuticals, cosmetics and biotechnological domains so as to develop new drugs and health-friendly products without using chemicals and toxic ingredients, enabling medical researchers to recommend and develop all natural healthcare products abiding by the legal compliance and governmental regulations.

Contact Information

Website
www.pierre-fabre.com
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Primary Office
  • 12, Avenue Hoche
  • 75008 Paris
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pierre Fabre Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medica
Pharmaceuticals
Paris, France
9,600 As of 2023

000000

at. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
000000000000000
Mumbai, India
0000 As of 0000
00000000

000000

ure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
000000000000000
Basel, Switzerland
00000 As of 0000
000000000-00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pierre Fabre Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbott India Corporation Mumbai, India 0000 00000000
000000 00000000000 Corporate Backed or Acquired Basel, Switzerland 00000 000000000-00
0000000000 0000000 Corporation Ingelheim Am Rhein, Germany 00000
000000000000000 00 Corporation Lagos, Nigeria 00
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 0000000000
You’re viewing 5 of 16 competitors. Get the full list »

Pierre Fabre Patents

  • 3,794

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 185

    Granted

  • 34

    Pending

  • 000

    Expiring in next 12 mo

Pierre Fabre Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4172212-A1 New stable anti-vista antibody Pending 30-Apr-2021 00000000000
AU-2021358394-A1 Combination of encorafenib and binimetinib as adjuvant treatment for resected stage ii melanoma Pending 05-Oct-2020 000000000
EP-4225307-A1 Combination of encorafenib and binimetinib as adjuvant treatment for resected stage ii melanoma Pending 05-Oct-2020 000000000
EP-4126964-A1 A protein complex comprising an immunocytokine Pending 01-Apr-2020 00000000000
EP-3889183-A1 A protein complex comprising an immunocytokine Inactive 01-Apr-2020 C07K14/5443 00
To view Pierre Fabre’s complete patent history, request access »

Pierre Fabre Executive Team (11)

Name Title Board Seat Contact Info
Eric Ducournau Chief Executive Officer
Vincent Huraux Chief Operating Officer
Damien Baur Director, Mergers & Acquisitions and Consumer
Laurent Fredon International Market Access Project Manager
Eric Gouy Senior Vice President, Administration, Finance & Legal
You’re viewing 5 of 11 executive team members. Get the full list »

Pierre Fabre Board Members (3)

Name Representing Role Since
Isabelle Girolami Self Chairman of the Audit Committee, Member of the Strategic Committee & Supervisory Board 000 0000
Pierre-Yves Revol Pierre Fabre Vice Chairman of Supervisory Board and Member of Audit, Nomination, Strategic and Remuneration Committee 000 0000
Roch Doliveux Self Chairman of the Supervisory Board and Strategic Committee and Member of the Nomination and Remuneration Committee 000 0000
To view Pierre Fabre’s complete board members history, request access »

Pierre Fabre Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pierre Fabre Investments & Acquisitions (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 20-Sep-2023 00000 0000 0000 Drug Discovery
00000000 000 12-Sep-2023 0000000000 Biotechnology 0000 0000
0ê00 12-Apr-2023 0000000000 Personal Products
000000000 000 10-Oct-2022 000000000 Drug Discovery 0000 0000
La Drôme Provençale 22-Nov-2021 Merger/Acquisition Personal Products 0000 0000
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Pierre Fabre Subsidiaries (3)

Company Name Industry Location Founded
Même Personal Products Paris, France 2015
00 00ô00 000000ç00 Personal Products Saillans, France 0000
000000 00000 00000 Other Commercial Products Castres, France
To view Pierre Fabre’s complete subsidiaries history, request access »

Pierre Fabre Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 09-Apr-2021 00000 00000 00 000.00 Completed
  • 6 buyers
0000000 28-Apr-2015 00000 00000 00 00000 Completed
  • 000000 00000
Rovafarm Argentina 01-Jan-1989 Merger/Acquisition Completed
To view Pierre Fabre’s complete exits history, request access »